D T Curiel
- Genetics top 2%
- Virus-based gene therapy research 14
- Oncology top 5%
- CAR-T cell therapy research 8
- HER2/EGFR in Cancer Research 5
- Biotechnology top 5%
- Molecular Biology top 10%
- Viral Infectious Diseases and Gene Expression in Insects 7
- RNA Interference and Gene Delivery 5
- Glycosylation and Glycoproteins Research 2
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Viral gastroenteritis research and epidemiology 1
- Co-authors
- Paul N. ReynoldsIgor P. DmitrievRonald D. AlvarezJessy S. DeshaneSergei M. DanilovW E GrizzleIrina V. BalyasnikovaJeffrey A. Engler
- Cited by
- GeneticsOncologyBiotechnology
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Molecular Therapy (1 paper)Current Gene Therapy (1 paper)
- Partner nations
- United StatesFranceFinland
In The Last Decade
D T Curiel
21 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 63
- Genetics 1.0k
- Oncology 660
- Biotechnology 171
- Molecular Biology 1.0k
- Radiology, Nuclear Medicine and Imaging 203
Countries citing papers authored by D T Curiel
This map shows the geographic impact of D T Curiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D T Curiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D T Curiel more than expected).
Fields of papers citing papers by D T Curiel
This network shows the impact of papers produced by D T Curiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D T Curiel. The network helps show where D T Curiel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D T Curiel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 65 | |
| 2 | 2001 | 172 | |
| 3 | Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells. | 2001 | 120 |
| 4 | Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule. | 2001 | 63 |
| 5 | A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. | 2000 | 134 |
| 6 | 2000 | 164 | |
| 7 | 1999 | 11 | |
| 8 | 1999 | 142 | |
| 9 | 1999 | 97 | |
| 10 | 1998 | 8 | |
| 11 | 1998 | 4 | |
| 12 | Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. | 1997 | 74 |
| 13 | Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus. | 1997 | 26 |
| 14 | Novel gene therapy strategy to accomplish growth factor modulation induces enhanced tumor cell chemosensitivity. | 1996 | 20 |
| 15 | 1996 | 21 | |
| 16 | 1995 | 87 | |
| 17 | Complementation of a human adenovirus early region 4 deletion mutant in 293 cells using adenovirus-polylysine-DNA complexes. | 1995 | 11 |
| 18 | Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. | 1995 | 94 |
| 19 | Addition of a short peptide ligand to the adenovirus fiber protein. | 1995 | 122 |
| 20 | Rapid protection against human immunodeficiency virus type 1 (HIV-1) replication mediated by high efficiency non-retroviral delivery of genes interfering with HIV-1 tat and gag. | 1994 | 18 |
About D T Curiel
D T Curiel is a scholar working on Genetics, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), CAR-T cell therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers), RNA Interference and Gene Delivery (5 papers), Glycosylation and Glycoproteins Research (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Genetics (1.0k citations), Oncology (660 citations) and Biotechnology (171 citations). D T Curiel has collaborated with scholars based in United States, France and Finland. Frequent co-authors include Paul N. Reynolds, Igor P. Dmitriev, Ronald D. Alvarez, Jessy S. Deshane, Sergei M. Danilov, W E Grizzle, Irina V. Balyasnikova, Jeffrey A. Engler, Jeong S. Hong and Gustavo Cabrera. Their work appears in journals such as Biochemical and Biophysical Research Communications, Molecular Therapy, Current Gene Therapy, European Journal of Cancer and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.